These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 2719010)

  • 21. Mallory bodies in alcoholic and non-alcoholic liver disease contain a common antigenic determinant.
    Fleming KA; Morton JA; Barbatis C; Burns J; Canning S; McGee JO
    Gut; 1981 May; 22(5):341-4. PubMed ID: 6166516
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Is apoptosis involved in alcoholic hepatitis?
    Kawahara H; Matsuda Y; Takase S
    Alcohol Alcohol Suppl; 1994; 29(1):113-8. PubMed ID: 9063809
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinical significance of hepatitis GB virus C infection in alcoholic liver disease.
    Tsutsumi M; Sawada M; Takase S; Chen WB; Ueshima Y; Tsuchishima M; Shimanaka K; Itoh T; Kawahara H
    Alcohol Clin Exp Res; 1997 Dec; 21(9):1722-5. PubMed ID: 9438537
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Distribution patterns of cytokeratin antigen determinants in alcoholic and nonalcoholic liver diseases.
    Ray MB
    Hum Pathol; 1987 Jan; 18(1):61-6. PubMed ID: 2434406
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prognosis for the patients with alcoholic and nonalcoholic liver disease.
    Colić-Cvrlje V; Naumovski-Mihalić S; Prskalo M; Colić A; Cvjeticanin B; Sabarić B
    Coll Antropol; 2000 Jun; 24(1):249-52. PubMed ID: 10895552
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Disappearance of Mallory bodies in the liver of autopsy cases with a history of heavy drinking].
    Iwaba A; Kishi M; Nakazawa H; Ogata S; Koike J; Aida Y; Maeyama S; Uchikoshi T
    Nihon Arukoru Yakubutsu Igakkai Zasshi; 1999 Jun; 34(3):153-60. PubMed ID: 10424110
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Diencephalic and cerebellar pathology in alcoholic and nonalcoholic patients with end-stage liver disease.
    Kril JJ; Butterworth RF
    Hepatology; 1997 Oct; 26(4):837-41. PubMed ID: 9328301
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Serum leptin levels in patients with nonalcoholic chronic liver disease.
    Nakamuta M; Tada S; Uchimura K; Enjoji M; Kinukawa N; Iwamoto H; Sugimoto R; Shimada M; Ohashi M; Sugimachi K; Nawata H
    Hepatogastroenterology; 2001; 48(38):527-32. PubMed ID: 11379347
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Immunohistochemical study of hyaluronate receptor (CD44) in alcoholic liver disease.
    Urashima S; Tsutsumi M; Ozaki K; Tsuchishima M; Shimanaka K; Ueshima Y; Takase S
    Alcohol Clin Exp Res; 2000 Apr; 24(4 Suppl):34S-38S. PubMed ID: 10803777
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Ultrastructural heterogeneity and assumed mode of formation of Mallory bodies in acute alcoholic hepatitis and in experimental hepatitis].
    Vic P; Sablier G; Humeau C; Sentein P; Michel H
    C R Seances Acad Sci D; 1980 Sep; 291(3):341-7. PubMed ID: 6777056
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Changes in type IV collagen content in livers of patients with alcoholic liver disease.
    Tsutsumi M; Urashima S; Matsuda Y; Takase S; Takada A
    Hepatology; 1993 May; 17(5):820-7. PubMed ID: 8491450
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Light and electron microscopy findings in alcoholic liver damage].
    Chlumská A; Dobiás J; Chlumský J; Krtek V
    Zentralbl Allg Pathol; 1985; 130(6):529-32. PubMed ID: 3834712
    [TBL] [Abstract][Full Text] [Related]  

  • 33. High molecular weight components are main constituents of Mallory bodies isolated with a fluorescence activated cell sorter.
    Zatloukal K; Böck G; Rainer I; Denk H; Weber K
    Lab Invest; 1991 Feb; 64(2):200-6. PubMed ID: 1705301
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mallory bodies--immunohistochemical detection by antisera to unique non-prekeratin components.
    Morton JA; Fleming KA; Trowell JM; McGee JO
    Gut; 1980 Sep; 21(9):727-33. PubMed ID: 7000633
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Isolation and electrophoretic study on Mallory bodies from the livers of alcoholic cirrhosis.
    Okamura K; Harwood TR; Yokoo H
    Lab Invest; 1975 Aug; 33(2):193-9. PubMed ID: 51133
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Focal nodular hyperplasia of the liver: ultrastructural observations.
    Wessely Z; Shapiro SH; Scherer JD
    Ann Clin Lab Sci; 1982; 12(2):119-25. PubMed ID: 7073237
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Relative versus absolute carbohydrate-deficient transferrin as a marker of alcohol consumption in patients with acute alcoholic hepatitis.
    Halm U; Tannapfel A; Mössner J; Berr F
    Alcohol Clin Exp Res; 1999 Oct; 23(10):1614-8. PubMed ID: 10549992
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparative electrophoretic study of Mallory body and intermediate filament protein.
    Sim JS; Franks KE; French SW
    J Med; 1978; 9(3):211-21. PubMed ID: 283168
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mallory bodies compared with microfilament hyperplasia.
    Sim JS; Franks KE; French SW; Caldwell MG
    Arch Pathol Lab Med; 1977 Aug; 101(8):401-4. PubMed ID: 195552
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Disease- and cell-specific expression of GP73 in human liver disease.
    Iftikhar R; Kladney RD; Havlioglu N; Schmitt-Gräff A; Gusmirovic I; Solomon H; Luxon BA; Bacon BR; Fimmel CJ
    Am J Gastroenterol; 2004 Jun; 99(6):1087-95. PubMed ID: 15180730
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.